VCP ScannerFree US Stock Screener & Financial AnalysisFree US Stock Screener
ScreenerThemes
DCF ValuationCalculate intrinsic value of US stocks
Market ValuationBuffett indicator, CAPE & macro gauges
Total ReturnSee dividends + price return history
DCA CalculatorSimulate recurring buys & compounding
Earnings
FAANG & Tech
AAPL vs MSFTNVDA vs AMDGOOGL vs META
Cloud & Cyber
CRM vs NOWCRWD vs PANWSNOW vs DDOG
Consumer & Auto
TSLA vs FAMZN vs WMTNFLX vs DIS
Finance & Crypto
JPM vs BACV vs MACOIN vs MSTR
Pharma & Energy
LLY vs NVOJNJ vs PFEXOM vs CVX
Compare Any Stocks...
WatchlistInsider
ScreenerThemes
Earnings
WatchlistInsider
DSGN
← Back to Screener
VCP ScannerFree US Stock Screener & Financial Analysis

Find stocks. Verify deeply. Act with conviction.

Data updated daily

Product

  • Screener
  • Themes
  • Valuation
  • Total Return
  • DCA Calculator
  • News
  • Earnings

Resources

  • Market Valuation
  • Compare
  • Insider Activity
  • Methodology
  • How It Works
  • Glossary
  • Learn

Get Ideas

Get weekly stock ideas — free

© 2026 VCP Scanner
AboutPrivacyTerms
Not financial advice. Do your own research.
ScreenerNewsCompareWatchlist
DSGNDesign Therapeutics, Inc.
$14.24$889M
Overview & Verdict
Overview
Valuation & Forecasts
Valuation ModelsEstimatesDCF Model
Price & Analyst Data
Analyst TargetsPrice HistoryTechnical Analysis
Financial Statements
Income StatementBalance SheetCash FlowRatios & Margins
Performance
P/E HistoryRevenue HistoryEarnings HistoryDividend HistoryTotal Return
Ownership
Holders
HomeStocksDSGNQuarterly Financials

Design Therapeutics, Inc. (DSGN) Quarterly Financials

120+ quarters historyFree accessUpdated daily

Design Therapeutics, Inc. (DSGN) quarterly income statement — complete revenue, gross profit & net income history

DSGN Income Statement

Income StatementBalance SheetCash FlowRatios
AnnualQuarterly
MetricQ1'26Q4'25Q3'25Q2'25Q1'25Q4'24Q3'24Q2'24Q1'24Q4'23Q3'23Q2'23Q1'23Q4'22Q3'22Q2'22Q1'22Q4'21Q3'21Q2'21
Sales/Revenue00000000000000000000
Revenue Growth %--------------------
Cost of Goods Sold0-14.74M14.59M152K000151K143K0137K000000000
COGS % of Revenue--------------------
Gross Profit014.74M-14.59M-152K000-151K-143K0-137K000000000
Gross Margin %--------------------
Gross Profit Growth %----0.66%100%-100%-------------
Operating Expenses19.71M32.91M4.72M21.42M20.42M16.69M16.25M14.89M14.26M15.12M18.68M22.6M21.65M19.39M19.19M15.64M13.37M11.13M11.34M7.69M
OpEx % of Revenue--------------------
Selling, General & Admin5.33M4.74M4.72M5.83M5.04M4.54M4.37M4.53M4.6M4.11M5.57M5.53M5.92M5.14M4.89M4.34M4.61M3.79M2.8M2.66M
SG&A % of Revenue--------------------
Research & Development14.38M13.43M14.59M15.74M15.38M12.16M11.88M10.37M9.66M11.01M13.26M17.06M15.73M14.26M14.3M11.29M8.76M7.34M8.54M5.03M
R&D % of Revenue--------------------
Other Operating Expenses01000K-1000K-152K000000-137K000000000
Operating Income-19.71M-18.17M-19.31M-21.57M-20.42M-16.69M-16.25M-15.04M-14.4M-15.12M-18.82M-22.6M-21.65M-19.39M-19.19M-15.64M-13.37M-11.13M-11.34M-7.69M
Operating Margin %--------------------
Operating Income Growth %3.49%-8.84%-18.87%-43.38%-41.79%-10.4%13.69%33.43%33.49%22.02%1.93%-44.48%-61.94%-74.28%-69.29%-103.45%-135.39%-188.19%--
EBITDA-19.71M-18.01M-19.16M-21.42M-20.26M-16.55M-16.09M-14.89M-14.26M-14.98M-18.68M-22.46M-21.52M-19.27M-19.08M-15.55M-13.29M-11.04M-11.31M-7.67M
EBITDA Margin %--------------------
EBITDA Growth %2.73%-8.87%-19.03%-43.82%-42.1%-10.43%13.87%33.7%33.76%22.24%2.09%-44.48%-61.97%-74.45%-68.8%-102.57%-134.11%-186.36%--
D&A (Non-Cash Add-back)0156K155K152K159K149K153K151K143K138K137K133K129K124K108K92K82K82K31K12K
EBIT0-18.17M-17M-19.08M-20.42M-16.69M-16.25M-15.04M-14.4M-15.12M-18.82M-22.6M-21.65M-19.39M-19.19M-15.64M-13.37M-11.13M-11.34M-7.69M
Net Interest Income02.17M2.31M2.49M2.7M3.04M00000000000000
Interest Income2.07M2.17M2.31M2.49M2.7M3.04M00000000000000
Interest Expense00000000000000000000
Other Income/Expense2.07M2.17M2.31M2.49M2.7M3.04M3.21M3.25M3.29M3.28M3.03M2.66M2.36M2.05M1.49M640K105K62K19K51K
Pretax Income-17.64M-16M-17M-19.08M-17.71M-13.65M-13.04M-11.79M-11.11M-11.84M-15.79M-19.94M-19.29M-17.34M-17.7M-15M-13.27M-11.06M-11.32M-7.64M
Pretax Margin %--------------------
Income Tax00000000000000000000
Effective Tax Rate %0%0%0%0%0%0%0%0%0%0%0%0%0%0%0%0%0%0%0%0%
Net Income-17.64M-16M-17M-19.08M-17.71M-13.65M-13.04M-11.79M-11.11M-11.84M-15.79M-19.94M-19.29M-17.34M-17.7M-15M-13.27M-11.06M-11.32M-7.64M
Net Margin %--------------------
Net Income Growth %0.45%-17.19%-30.36%-61.82%-59.52%-15.28%17.42%40.85%42.44%31.71%10.82%-32.92%-45.45%-56.71%-56.42%-96.42%-140.57%-187.03%--
Net Income (Continuing)-17.64M-16M-17M-19.08M-17.71M-13.65M-13.04M-11.79M-11.11M-11.84M-15.79M-19.94M-19.29M-17.34M-17.7M-15M-13.27M-11.06M-11.32M-7.64M
Discontinued Operations00000000000000000000
Minority Interest00000000000000000000
EPS (Diluted)-0.29-0.27-0.30-0.34-0.31-0.24-0.23-0.21-0.20-0.21-0.28-0.36-0.30-0.27-0.29-0.26-0.24-0.20-0.21-0.14
EPS Growth %6.45%-12.5%-30.43%-61.9%-55%-14.29%17.86%41.67%33.33%22.22%3.45%-38.46%-25%-35%-38.1%-85.71%22.58%-42.86%--
EPS (Basic)-0.29-0.27-0.30-0.34-0.31-0.24-0.23-0.21-0.20-0.21-0.28-0.36-0.30-0.27-0.29-0.26-0.24-0.20-0.21-0.14
Diluted Shares Outstanding61.43M57.33M56.95M56.86M56.76M56.68M56.62M56.56M56.49M56.15M55.99M55.95M55.91M55.86M55.78M55.67M55.51M55.36M55.16M55.08M
Basic Shares Outstanding61.43M57.33M56.95M56.86M56.76M56.68M56.62M56.56M56.49M56.15M55.99M55.95M55.91M55.86M55.78M55.67M55.51M55.36M55.16M55.08M
Dividend Payout Ratio--------------------